Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by MicroRNA 491-3ps

Journal of Pharmacology and Experimental Therapeutics

Volumn 348, Issue 3, 2014, Pages 465-477

  Dluzen, Douglas F ^a   Sun, Dongxiao ^a   Salzberg, Anna C ^b   Jones, Nate ^a   Bushey, Ryan T ^a   Robertson, Gavin P ^a   Lazarus, Philip ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A6; MICRORNA; MICRORNA 491 3P; RALOXIFENE; RALOXIFENE 4' GLUCURONIDE; RALOXIFENE 6 GLUCURONIDE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL LINE; CELL STRAIN HEPG2; CELL STRAIN HUH 7; COMPUTER MODEL; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG METABOLISM; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA BINDING; UGT1A GENE;

CELL LINE, TUMOR; COMPUTER SIMULATION; EPIRUBICIN; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HEK293 CELLS; HUMANS; LIVER; LUCIFERASES, RENILLA; MICRORNAS; ORGAN SPECIFICITY; PROTEIN BINDING; RALOXIFENE; RNA, MESSENGER;

EID: 84896732683     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.210658     Document Type: Article

References (60)

1. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, and Bartel DP (2008) The impact of microRNAs on protein output. Nature 455:64-71.
2. Balliet RM, Chen G, Gallagher CJ, Dellinger RW, Sun D, and Lazarus P (2009) Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype. Cancer Res 69:2981-2989.
3. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
4. Bélanger A, Pelletier G, Labrie F, Barbier O, and Chouinard S (2003) Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479.
5. Betel D, Wilson M, Gabow A, Marks DS, and Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36 (Database issue): D149-D153.
6. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, Chowdhury NR, and Jansen PL (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269: 17960-17964.
7. Bushey RT and Lazarus P (2012) Identification and functional characterization of a novel UDP-glucuronosyltransferase 2A1 splice variant: potential importance in tobacco-related cancer susceptibility. J Pharmacol Exp Ther 343:712-724.
8. Carthew RW and Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655.
9. Chen G, Blevins-Primeau AS, Dellinger RW, Muscat JE, and Lazarus P (2007) Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp.Tyr) polymorphism. Cancer Res 67:9024-9029.
10. Chen G, Dellinger RW, Sun D, Spratt TE, and Lazarus P (2008) Glucuronidation of tobacco-specific nitrosamines by UGT2B10. Drug Metab Dispos 36:824-830.
11. Chen G, Giambrone NE, Jr, Dluzen DF, Muscat JE, Berg A, Gallagher CJ, and Lazarus P (2010) Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms. Cancer Res 70:7543-7552.
12. Chen G, Giambrone NE, and Lazarus P (2012) Glucuronidation of trans-39-hydroxycotinine by UGT2B17 and UGT2B10. Pharmacogenet Genomics 22:183-190.
13. Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, and Mackenzie PI (2001) Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998-1006.
14. Dellinger RW, Chen G, Blevins-Primeau AS, Krzeminski J, Amin S, and Lazarus P (2007) Glucuronidation of PhIP and N-OH-PhIP by UDP- glucuronosyltransferase 1A10. Carcinogenesis 28:2412-2418.
15. Enright AJ, John B, Gaul U, Tuschl T, Sander C, and Marks DS (2003) MicroRNA targets in Drosophila. Genome Biol 5:R1.
16. Gallagher CJ, Balliet RM, Sun D, Chen G, and Lazarus P (2010) Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity. Drug Metab Dispos 38: 2204-2209.
17. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, and Bartel DP (2011) Weak seedpairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18:1139-1146.
18. Gruber AR, Lorenz R, Bernhart SH, Neuböck R, and Hofacker IL (2008) The Vienna RNA websuite. Nucleic Acids Res 36(Web Server issue):W70-74.
19. Guo H, Ingolia NT, Weissman JS, and Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835-840.
20. Haas U, Sczakiel G, and Laufer SD (2012) MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 39-UTR via altered RNA structure. RNA Biol 9:924-937.
21. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, and Hadzopoulou-Cladaras M, et al. (2011) An HNF4a-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147:1233-1247.
22. Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, and McLeod HL (2007) UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst 99: 1290-1295.
23. Hu W, Wang X, Ding X, Li Y, Zhang X, Xie P, Yang J, and Wang S (2012) MicroRNA-141 represses HBV replication by targeting PPARA. PLoS ONE 7:e34165.
24. Innocenti F, Iyer L, Ramírez J, Green MD, and Ratain MJ (2001) Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Drug Metab Dispos 29:686-692.
25. Izukawa T, Nakajima M, Fujiwara R, Yamanaka H, Fukami T, Takamiya M, Aoki Y, Ikushiro S, Sakaki T, and Yokoi T (2009) Quantitative analysis of UDPglucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos 37:1759-1768.
26. John B, Enright AJ, Aravin A, Tuschl T, Sander C, and Marks DS (2004) Human MicroRNA targets. PLoS Biol 2:e363.
27. Jones NR, Sun D, Freeman WM, and Lazarus P (2012) Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity. J Pharmacol Exp Ther 342:720-729.
28. Jordan VC, Gapstur S, and Morrow M (2001) Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 93:1449-1457.
29. Kemp DC, Fan PW, and Stevens JC (2002) Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. Drug Metab Dispos 30:694-700.
30. Khraiwesh B, Arif MA, Seumel GI, Ossowski S, Weigel D, Reski R, and Frank W (2010) Transcriptional control of gene expression by microRNAs. Cell 140:111-122.
31. Kida K, Nakajima M, Mohri T, Oda Y, Takagi S, Fukami T, and Yokoi T (2011) PPARa is regulated by miR-21 and miR-27b in human liver. Pharm Res 28: 2467-2476.
32. Komagata S, Nakajima M, Takagi S, Mohri T, Taniya T, and Yokoi T (2009) Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol Pharmacol 76:702-709.
33. Lazarus P, Blevins-Primeau AS, Zheng Y, and Sun D (2009) Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen. Ann N Y Acad Sci 1155:99-111.
34. Lewis BP, Burge CB, and Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
35. Liu DZ, Ander BP, Tian Y, Stamova B, Jickling GC, Davis RR, and Sharp FR (2012) Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells. Gene 495:120-127.
36. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
37. Macfarlane LA and Murphy PR (2010) MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics 11:537-561.
38. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15: 677-685.
39. Mackenzie PI, Hu DG, and Gardner-Stephen DA (2010) The regulation of UDPglucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors. Drug Metab Rev 42:99-109.
40. Mizuma T (2009) Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10. Int J Pharm 378:140-141.
41. Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, and Yokoi T (2010) Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79:1045-1052.
42. Mukherji S, Ebert MS, Zheng GX, Tsang JS, Sharp PA, and van Oudenaarden A (2011) MicroRNAs can generate thresholds in target gene expression. Nat Genet 43:854-859.
43. Nagar S and Blanchard RL (2006) Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab Rev 38:393-409.
44. Nagar S and Remmel RP (2006) Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene 25:1659-1672.
45. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, and Yokoi T (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461-1464.
46. Oda S, Nakajima M, Hatakeyama M, Fukami T, and Yokoi T (2012) Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissues. Drug Metab Dispos 40:1620-1627.
47. Ohno S and Nakajin S (2009) Determination of mRNA expression of human UDPglucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32-40.
48. Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, IshiguroN, Kishimoto W, Ludwig-Schwellinger E, and Ebner T, et al. (2012) Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities. Drug Metab Dispos 40:83-92.
49. Pan YZ, Gao W, and Yu AM (2009) MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112-2117.
50. Roff AN, Panganiban RP, Bond JS, and Ishmael FT (2013) Post-transcriptional regulation of meprin a by the RNA-binding proteins Hu antigen R (HuR) and tristetraprolin (TTP). J Biol Chem 288:4733-4743.
51. Rowland A, Miners JO, and Mackenzie PI (2013) The UDP- glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol 45: 1121-1132.
52. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, and Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455:58-63.
53. Sun D, Jones NR, Manni A, and Lazarus P (2013) Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo. Cancer Prev Res (Phila) 6:719-730.
54. Sun D, Sharma AK, Dellinger RW, Blevins-Primeau AS, Balliet RM, Chen G, Boyiri T, Amin S, and Lazarus P (2007) Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Drug Metab Dispos 35:2006-2014.
55. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, and Yokoi T (2010) Micro-RNAs regulate human hepatocyte nuclear factor 4a, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 285:4415-4422.
56. Trdan Lusin T, Trontelj J, and Mrhar A (2011) Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism. Drug Metab Dispos 39:2347-2354.
57. Tsuchiya Y, Nakajima M, Takagi S, Taniya T, and Yokoi T (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66:9090-9098.
58. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, and Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659.
59. Wiener D, Fang JL, Dossett N, and Lazarus P (2004) Correlation between UDPglucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone glucuronidation phenotype in human liver microsomes. Cancer Res 64: 1190-1196.
60. Zaya MJ, Hines RN, and Stevens JC (2006) Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab Dispos 34:2097-2101.